FGF21 and type 2 diabetes mellitus: Similar effects on the bone-turnover markers were also found n T2DM human patients in a trial for FGF21 analogue PF-05231023, where N-terminal propeptides and C-telopeptide cross-linking of type 1 collage were altered [210].